Spain Moves To Upgrade Its Scientific Standing

MADRID—With 1992 and European commercial integration fast approaching, Spain has taken measures to launch itself into the mainstream of European science, boosting the funding and training of its scientists and taking key steps to attract foreign technology-based industries. While Spanish scientists are pleased with these measures, they also regard them as inadequate if Spain intends to compete successfully in the new, unified, high-tech Europe. “Seven years ago, Spain was at

Written byMalen Ruiz De Elvira
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

MADRID—With 1992 and European commercial integration fast approaching, Spain has taken measures to launch itself into the mainstream of European science, boosting the funding and training of its scientists and taking key steps to attract foreign technology-based industries.

While Spanish scientists are pleased with these measures, they also regard them as inadequate if Spain intends to compete successfully in the new, unified, high-tech Europe.

“Seven years ago, Spain was at the end of the European train with Portugal and Greece—and well behind Ireland—in the amount we spent on science as a fraction of gross domestic product,” says biochemist Emilio Munoz, president of the National Research Council and one of the principal architects of Spain’s new Law for-Science. “Today, we are well in front of Portugal, Greece, and Ireland. We are even getting close to Belgium and Italy, countries of a similar industrial and commercial level to Spain.” And within the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies